Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL

Completed · Phase 2

Conditions studied: Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Mature B-Cell

In brief

This is a pilot study to demonstrate that the modified LMB-89 treatment regimen for children with newly diagnosed small noncleaved cell NHL, large cell NHL (B-cell), and B-cell acute lymphoblastic leukemia can be delivered in this setting with acceptable toxicity.

Key facts

Study ID

NCT00187161

Run by

St. Jude Children's Research Hospital

People needed

68

Starts

1994-11-01

Expected to finish

2007-01-01

Last updated by the study team

2008-06-04

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject must be previously untreated, except for steroids.
• Subject must be less than or equal to 18 years of age.
• Subject must have a histologic diagnosis of small noncleaved cell (SNCC) NHL or large cell NHL (B-cell), or B-cell acute lymphocytic leukemia.

You may not qualify if…

• Previously treated disease

Where it is running

• St. Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.